Exicure, INC

Exicure, Inc. announces director resignation, board expansion, new director appointments, and the formation of a Compensation Committee, effective June 30, 2026.

Exicure, Inc. announced it received a Nasdaq delinquency notice for a delayed 10-Q filing due to personnel changes, but has since filed the report and believes it has regained compliance.

Exicure, Inc. announces the appointment of Yoontae Han as a director and Young Seung Ko as Chief Operating Officer, alongside a change in Audit Committee Chair.

Exicure has reached a settlement in consolidated stockholder derivative litigation involving corporate governance reforms.

Exicure, Inc. announced the resignation of Sangjin Yeo from its Board of Directors and Audit Committee, effective March 27, 2026, citing no disagreements.

Exicure, Inc. announced its full year 2025 financial results, revealing a significant decrease in cash and a going concern warning despite a reduced net loss driven by a one-time gain.

Exicure, Inc. reported a net loss of $1.12 million for Q2 2026, with cash reserves insufficient for 12 months of operations, raising substantial doubt about its going concern status.

Exicure reports a net loss of $1.8 million for Q1 2026 and warns of substantial doubt regarding its ability to continue as a going concern.

Exicure, Inc. reported an increased net loss for Q3 2025 and expressed substantial doubt about its ability to continue as a going concern, despite strategic shifts into new biotechnology and entertainment ventures.

Exicure, Inc. reports a net income for the six months ended June 30, 2025, driven by a significant lease termination gain, but faces substantial doubt about its ability to continue as a going concern due to insufficient cash.

Exicure, Inc. reported a net income of $3.010 million for the first quarter of 2025, primarily due to a significant gain from early lease termination, as the company continues its strategic shift into new business areas while facing substantial doubt about its ability to continue as a going concern.

Exicure Inc. reported its third quarter 2024 results, highlighting a strategic shift towards exploring new opportunities while facing significant financial challenges and going concern doubts.

Exicure, Inc. reports a net loss of $4.9 million for 2025, continues to explore strategic alternatives, and faces substantial doubt about its ability to continue as a going concern.

Exicure, Inc. reports its full year 2024 results, highlighting a strategic shift towards exploring growth opportunities and addressing significant financial challenges, including a going concern uncertainty.

Exicure, Inc.'s annual report reveals a company in transition, halting research and development, exploring strategic alternatives, and facing significant financial challenges.

Exicure HiTron Inc. reported changes in beneficial ownership of Exicure, Inc. common stock on June 23, 2026.

Exicure's Chief Accounting Officer, Josh Miller, disposed of 8 shares of common stock to cover tax obligations related to restricted stock unit vesting.

Exicure HiTron Inc., a 10% owner and director of EXICURE, INC., reported the sale of 258,367 shares of common stock at $4.50 per share.

Exicure HiTron Inc., a director and 10% owner of Exicure, Inc., reported the sale of 734,747 common shares at $4.50 per share.

Exicure HiTron Inc., a 10% owner and director of EXICURE, INC., reported the sale of 741,272 shares of common stock at $4.50 per share.

Sangsangin Investment & Securities Co., Ltd. reported the sale of 433,332 shares of Exicure, Inc. common stock at $8.71 per share, reducing its beneficial ownership to zero.

Exicure, Inc. announces its 2025 Annual Meeting of Stockholders to be held virtually on November 6, 2025, to vote on director elections, auditor ratification, and executive compensation.

Exicure, Inc. is seeking stockholder approval for a $8.7 million investment from HiTron Systems Inc., which would result in a change of control and is crucial for the company to avoid delisting from Nasdaq and potential bankruptcy.

Exicure, Inc. is seeking stockholder approval for a reverse stock split at its special meeting on August 15, 2024, to maintain compliance with Nasdaq's minimum bid price requirement.

Exicure, Inc. will hold a combined 2024 and 2023 Annual Meeting of Stockholders virtually on June 28, 2024, to elect directors, ratify the selection of Marcum LLP as the independent auditor, and vote on executive compensation matters.

Exicure, Inc. is undergoing a significant strategic shift, divesting historical biotechnology assets to focus on new ventures including a blood cancer clinical trial and Korean entertainment and renewable energy businesses, while actively raising capital to address substantial doubt about its ability to continue as a going concern.

Exicure HiTron Inc. amended its Schedule 13D filing to report the reacquisition of 623,277 shares of Exicure, Inc. common stock, increasing its beneficial ownership to approximately 34.9%.

Exicure HiTron Inc. has reduced its beneficial ownership in Exicure, Inc. by transferring 258,367 shares for $1.16 million for liquidity purposes.

Exicure HiTron Inc. has reduced its beneficial ownership in Exicure, Inc. to 29.2% after transferring 734,747 shares for $3.3 million.

Exicure HiTron Inc. completed the transfer of 741,272 shares of Exicure, Inc. common stock for $3.34 million, reducing its beneficial ownership to 40.7%.

Exicure HiTron Inc. updated its beneficial ownership filing, detailing board resignations and appointments, and the pledging of 1.6 million Exicure, Inc. shares as collateral for convertible bonds.

HiTron Systems Inc. has completed its second stock purchase in Exicure, Inc., increasing its beneficial ownership to 52.8% and appointing a majority of the Issuer's board members, including its new CEO and CFO.

Sangsangin Investment & Securities Co., Ltd., Sangsangin Co., Ltd., and Jun Won Yoo filed an amended Schedule 13G, reporting zero beneficial ownership in Exicure, Inc. common stock.